- Home
- BTAI vs EDBL Comparison
BTAI vs EDBL Comparison
Compare BTAI & EDBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTAI
- EDBL
- Stock Information
- Founded
- BTAI 2017
- EDBL 2020
- Country
- BTAI United States
- EDBL United States
- Employees
- BTAI N/A
- EDBL N/A
- Industry
- BTAI Biotechnology: Pharmaceutical Preparations
- EDBL Farming/Seeds/Milling
- Sector
- BTAI Health Care
- EDBL Consumer Staples
- Exchange
- BTAI Nasdaq
- EDBL Nasdaq
- Market Cap
- BTAI 6.6M
- EDBL 6.8M
- IPO Year
- BTAI 2018
- EDBL 2022
- Fundamental
- Price
- BTAI $2.13
- EDBL $0.22
- Analyst Decision
- BTAI Buy
- EDBL
- Analyst Count
- BTAI 4
- EDBL 0
- Target Price
- BTAI $37.00
- EDBL N/A
- AVG Volume (30 Days)
- BTAI 279.4K
- EDBL 9.2M
- Earning Date
- BTAI 03-11-2025
- EDBL 03-31-2025
- Dividend Yield
- BTAI N/A
- EDBL N/A
- EPS Growth
- BTAI N/A
- EDBL N/A
- EPS
- BTAI N/A
- EDBL N/A
- Revenue
- BTAI $2,276,000.00
- EDBL $14,069,000.00
- Revenue This Year
- BTAI $105.36
- EDBL $2.43
- Revenue Next Year
- BTAI $46.93
- EDBL $42.42
- P/E Ratio
- BTAI N/A
- EDBL N/A
- Revenue Growth
- BTAI 83.25
- EDBL 7.88
- 52 Week Low
- BTAI $2.10
- EDBL $0.12
- 52 Week High
- BTAI $56.00
- EDBL $12.47
- Technical
- Relative Strength Index (RSI)
- BTAI 28.68
- EDBL 47.86
- Support Level
- BTAI $2.18
- EDBL $0.16
- Resistance Level
- BTAI $2.60
- EDBL $0.31
- Average True Range (ATR)
- BTAI 0.44
- EDBL 0.03
- MACD
- BTAI -0.08
- EDBL 0.00
- Stochastic Oscillator
- BTAI 0.94
- EDBL 37.84
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About EDBL Edible Garden AG Incorporated
Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses, together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces.